Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
about
Biological markers of invasive breast cancerDeciphering the divergent roles of progestogens in breast cancer.Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.Stratified pathway analysis to identify gene sets associated with oral contraceptive use and breast cancer.Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.Recent perspectives of breast cancer prognosis and predictive factors.A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning.Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.Estrogen and progesterone receptors in breast cancer.Steroid hormone receptors as prognostic markers in breast cancer.Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.Prognostic role of progesterone receptor expression in a population-based analysis.The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.Renewed interest in the progesterone receptor in breast cancer.Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases.GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network.Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancerA Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast DiseaseKi 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessmentBreast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patientsImpact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
P2860
Q26781177-CE2ED01C-1D6C-4E3C-A8FA-BA42733B89EBQ30240711-D7D8ECFE-C223-4FC3-9B20-AB7E80C6E47CQ33757796-7075CF5A-275F-4B5D-BE6F-553141310599Q33865098-8949B864-3641-481E-BB6D-5B802F3D6C80Q34514808-A9CB721F-4796-45FC-AF21-3B721DE89633Q34680457-3EB32032-6736-4B28-B608-4FA078EB9417Q35566057-ADF97BA5-1992-4484-BA67-79580240E569Q35781357-C131F8D1-82DD-4220-AFEB-7C5B3994862BQ36729240-E2ECB772-FB23-4FE6-A0BB-0159C5687228Q37056906-A470F905-BC7E-47A2-A4C4-DD74278CA6A5Q37407119-CD154EBE-89AC-45D0-9112-3ECBC6CDFF29Q37520800-225D7516-D8C4-4127-B34C-A064DAC8780CQ37701573-B53A3E65-81A0-4360-A33A-F7BC0009D5EEQ38282467-D68EB40C-D9F0-4EC0-ACB6-38EC90E68539Q38598704-7484DC43-7542-470C-8EBE-7A65874489BDQ39166261-3BEED0FE-F244-4E3D-9AF9-7B6180B7BD10Q39267625-1FE148F1-4E59-4311-9B70-984A299C4524Q40049115-C788D60D-D49D-4360-A586-A7198B8141E4Q40570290-26BD2C27-3DAD-4062-A2CE-5D7EF1C6B7EEQ40708757-C9682F17-0B02-4F36-B148-EFC91EC56EE4Q42383777-D1E2B0E2-FBC6-4777-B142-ADBF9E8AFB92Q47132011-86B809A5-B000-44C0-9B9E-D6072533BB73Q51671074-4BC932C3-E51C-44F5-BF77-3F3D588ED37AQ52430794-5EB3002E-15CF-4748-9B5E-0CCF404B0A25Q52885074-697C4D87-E8D6-4B0A-BEEE-1799A8A238EFQ52886152-3B20241A-5B55-4F45-9060-B90749BE1E70Q54330083-8C78CD4E-8670-4348-BDCF-E2C056C2F2FCQ57106904-4FB25542-3494-4921-96C1-8A532712B787Q58423595-C1086079-049C-430E-BA55-D0FEFB1296C7Q58698990-16DE0B47-F127-449A-8177-D3A545312F8FQ58703254-935C6697-3BA5-4D6D-AD42-9A3C9EC64383Q58799791-EC273371-EEF1-4BB1-BA5C-940B2178E6BB
P2860
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progesterone receptor expressi ...... cer: a population-based study.
@en
Progesterone receptor expressi ...... cer: a population-based study.
@nl
type
label
Progesterone receptor expressi ...... cer: a population-based study.
@en
Progesterone receptor expressi ...... cer: a population-based study.
@nl
prefLabel
Progesterone receptor expressi ...... cer: a population-based study.
@en
Progesterone receptor expressi ...... cer: a population-based study.
@nl
P2093
P2860
P356
P1476
Progesterone receptor expressi ...... cer: a population-based study.
@en
P2093
A Ashfield
A M Thompson
L B Jordan
P2860
P2888
P304
P356
10.1038/BJC.2013.756
P407
P577
2013-12-03T00:00:00Z